SCHEMBL3579519

SCHEMBL3579519

CCOC(=O)C1=C(c2ccccc2)c2ccc(OCCc3ccccn3)cc2C1=O

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.77
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
HSP90AA1 P07900 1/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
MPI P34949 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HKDC1 Q2TB90 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13316131 0.87 PPARG (1.00) PPARG
SCHEMBL3572505 0.84 PPARG (1.00) PPARG
SCHEMBL4656115 0.84 PPARG (0.57) PPARGKDM4EMEN1NPC1ALDH1A1
SCHEMBL4655615 0.81 PPARG (0.92) PPARG
SCHEMBL3572575 0.80 PPARG (1.00) PPARGKDM4EMEN1NPC1ALDH1A1
SCHEMBL4658647 0.80 PPARG (0.91) PPARGMEN1NPC1ALDH1A1MAPT
SCHEMBL13316147 0.78 PPARG (1.00) PPARG
SCHEMBL4657598 0.78 PPARG (0.86) PPARG
SCHEMBL4657596 0.78 PPARG (0.86) PPARG
SCHEMBL3569618 0.77 PPARG (0.59) PPARGTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745439-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-29 US disclosed
EP-1756036-A4 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RES INST CHEM TECH (KR) 2008-04-16 EP disclosed
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof JEIL PHARM. CO., LTD. (KR) 2007-09-27 US disclosed
EP-1756036-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Korea Research Institute of Chemical Technology (KR) 2007-02-28 EP disclosed
WO-2005100297-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof INSR, GPR119, PPARA PPARG 8/4885KDM4E 3150/4885MEN1 1971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.